http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2532330-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 |
filingDate | 2000-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c3780fdc391c0eba6f36c8c2012231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31873bfa50b83fb44cf54334c4157d0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f1f89dd1d8b965ec1d411ef5698382 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b865ef004fa9f6ce3b81c67031587a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a63bb520ebcbcf53a56b2bb2b00003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f37728a85d64fe15579c4d349778285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66bf4eec77cf9e987ace53f32978f005 |
publicationDate | 2009-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2532330-C |
titleOfInvention | Highly selective norepinephrine reuptake inhibitors and methods of using the same |
abstract | Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition wherein inhibiting reuptake of nonpinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (K i)/nonpinephrine (K i) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition. |
priorityDate | 1999-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.